Sedigheh Pakseresht
Guilan University of Medical Sciences, Iran
Posters & Accepted Abstracts: J Cancer Sci Ther
Statement of the Problem: With the advancement of cancer diagnostic and therapeutic methods, the total cost of
cancer treatment is increased. Cancellation costs can reduce patients' access to essential treatments and ultimately
impairment in health and quality of life. Due to high prevalence of cancer, increased survival, patient's therapeutic
needs and the development of expensive equipment, as a result, patients tolerate financial stress and stressful
conditions.
Aims: This study was conducted to determine the cost of treatment for cancer patients. This descriptive crosssectional
study was conducted to determine the cost of treatment for cancer patients in Rasht, Iran.
Material & Methods: Of all 412 records filed of cancer patients were documented in within 3years, 374 were included
in the study. A demographic questionnaire and patient medical records were used to collect data. Data were analyzed
by descriptive (frequency, mean, SD) and inferential tests (T test and ANOVA & Pearson).
Results: The results showed that the mean age of the samples was 14.77±51.50years. 45.2% of the samples had
gastrointestinal cancers and 14.2% had breast cancer and 13.9% had hematology. 12.3% of patients had metastases.
The average total cost of patients is 1749.99±1861.30$. The patient's contribution was 111.72±134.90$ and the
insurance contribution was 1495.66±1681.63$. There was a statistically significant relationship between the total cost
of the patients and the type of cancer (P=0.0001, F=11.3, DF=7) and the number of admissions (P=0.0001, r=0.5).
The economic impact of years after the diagnosis of cancer and the survivors of cancer is remarkable.
Conclusions: With the growing population of cancer survivors, efforts to reduce the economic burden of cancer will
become increasingly important.
E-mail: paksersht@yahoo.com
Cancer Science & Therapy received 5282 citations as per Google Scholar report